InvestorsHub Logo
Followers 66
Posts 12740
Boards Moderated 0
Alias Born 06/03/2015

Re: JKS3 post# 397699

Thursday, 01/12/2023 4:18:47 PM

Thursday, January 12, 2023 4:18:47 PM

Post# of 463744
Meaningless short-term data. What's important are the long-term benefits and blarcamesine is showing to be better than lecanecrud... the extension trial will continue to prove that.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News